Table: Zeria Pharm - 9-MTH group results
Feb 2 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2021 Dec 31, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 45.10 40.37 60.00
(+11.7 pct) (+13.7 pct)
Operating 5.50 3.88 5.30
(+41.6 pct) (+52.5 pct)
Recurring 5.61 3.56 5.20
(+57.6 pct) (+62.1 pct)
Net 4.04 3.70 3.70
(+9.2 pct) (+17.7 pct)
EPS 89.33 yen 80.18 yen 81.84 yen
Ann Div 34.00 yen 34.00 yen
-Q2 div 17.00 yen 17.00 yen
-Q4 div 17.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T